Optic neuritis

Comprehensive Ophthalmology Update

Volumn 8, Issue 2, 2007, Pages 67-75

  Vaphiades, Michael S ^a   Kline, Lanning B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Controlled high risk subjects avonex (Biogen Idec, Cambridge, MA) MS prevention study (CHAMPS); Multiple sclerosis; Neuromyelitis optica; Nonarteritic Anterior Ischemic Optic Neuropathy (NAION); Optic neuritis

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; INTERFERON BETA SERINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; RITUXIMAB; STEROID;

CLINICAL TRIAL; COLOR VISION DEFECT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FOLLOW UP; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MONOTHERAPY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC DISK; OPTIC NEURITIS; PUPIL DISEASE; REVIEW; TREATMENT FAILURE; VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

ADJUVANTS, IMMUNOLOGIC; ADRENAL CORTEX HORMONES; ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; OPTIC NEURITIS; RISK FACTORS; VISION DISORDERS;

EID: 34250335563     PISSN: 15277313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. ___: The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 109: 1673-8, 1991
2. Lepore FE: The origin of pain in optic neuritis. Determinants of pain in 101 eyes with optic neuritis. Arch Neurol 48: 748-9, 1991
3. Nikoskelainen E: Symptoms, signs and early course of optic neuritis. Acta Ophthalmol (Copenh) 53: 254-72, 1975
4. Beck RW, Gal RL, Bhatti MT, et al: Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 137: 77-83, 2004
5. Slamovitis TL, Rosen CE, Cheng KP, Striph GG: Visual recovery in patients with optic neuritis and visual loss to no light perception. Am J Ophthalmol 111: 209-14, 1991
6. Keltner JL, Johnson CA, Spurr JO, et al: Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 111: 231-4, 1993
7. Fang JP, Donahue SP, Lin RH: Global visual field involvement in acute unilateral optic neuritis. Am J Ophthalmol 128: 554-65, 1999
8. Beck RW, Kupersmith MJ, Cleary PA, et al: Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial. Ophthalmology 100: 691-7; discussion 697-8, 1993
9. Trip SA, Schlottmann PG, Jones SJ, et al: Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 31: 286-93, 2006
10. Rizzo JF, Lessell S: Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol 109: 1668-72, 1991
11. Miller DH, Newton MR, van der Poel JC, et al: Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 38: 175-9, 1988
12. Merandi SF, Kudryk BT, Murtagh FR, et al: Contrast-enhanced MR imaging of optic nerve lesions in patients with acute optic neuritis. AJNR Am J Neuroradiol 12: 923-6, 1991
13. Kupersmith MJ, Alban T, Zeiffer B, et al: Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 125: 812-22, 2002
14. Beck RW, Trobe JD, Moke PS, et al: High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121: 944-9, 2003
15. Beck RW, Cleary PA, Anderson MM, et al: A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326: 581-8, 1992
16. Beck RW, Cleary PA: Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 111: 773-5, 1993
17. Beck RW, Cleary PA, Trobe JD, et al: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med 329: 1764-9, 1993
18. Beck RW, Arrington J, Murtagh FR, et al: Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. Arch Neurol 50: 841-6, 1993
19. Morrissey SP, Miller DH, Kendall BE, et al: The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 116 (Pt 1): 135-46, 1993
20. Brex PA, Ciccarelli O, O'Riordan JI, et al: A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346: 158-64, 2002
21. Morrissey SP, Borruat FX, Miller DH, et al: Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry 58: 70-4, 1995
22. Beck RW: The optic neuritis treatment trial: three-year follow-up results. Arch Ophthalmol 113: 136-7, 1995
23. Stern BJ, Krumholz A, Johns C, et al: Sarcoidosis and its neurological manifestations. Arch Neurol 42: 909-17, 1985
24. Gelwan MJ, Kellen RI, Burde RM, et al: Sarcoidosis of the anterior visual pathway: successes and failures. J Neurol Neurosurg Psychiatry 51: 1473-80, 1988
25. Dutton JJ, Burde RM, Klingele TG: Autoimmune retrobulbar optic neuritis. Am J Ophthalmol 94: 11-7, 1982
26. Kupersmith MJ, Burde RM, Warren FA, et al: Autoimmune optic neuropathy: evaluation and treatment. J Neurol Neurosurg Psychiatry 51: 1381-6, 1988
27. Frohman L, Turbin R, Bielory L, et al: Autoimmune optic neuropathy with anticardiolipin antibody mimicking multiple sclerosis in a child. Am J Ophthalmol 136: 358-60, 2003
28. Frohman L, Bielory L, Warren F, et al: Skin biopsies in the evaluation of atypical optic neuropathies. Invest Ophthalmol Vis Sci 32 (Suppl): 951, 1991
29. Lessell S: Nonarteritic anterior ischemic optic neuropathy: enigma variations. Arch Ophthalmol 117: 386-8, 1999
30. Glaser JS: Part II. The optic nerve, in Glaser JS (ed): Neuro-ophthalmology. Philadelphia, Lippincott Williams & Wilkins, 1999, ed 3, pp 155-69
31. Vaphiades MS, Newman NJ: Optic nerve enhancement on orbital magnetic resonance imaging in Leber's hereditary optic neuropathy. J Neuroophthalmol 19: 238-9, 1999
32. Bhatti MT, Newman NJ: A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol 19: 28-33, 1999
33. Vaphiades MS: Disk edema and cranial MRI optic nerve enhancement: how long is too long?. Surv Ophthalmol 46: 56-8, 2001
34. Jacobs LD, Beck RW, Simon JH, et al: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343: 898-904, 2000
35. Comi G, Filippi M, Barkhof F, et al: Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357: 1576-82, 2001
36. Lublin F: History of modern multiple sclerosis therapy. J Neurol 252 Suppl 3: iii3-iii9, 2005
37. Hartung HP: Early treatment and dose optimisation BENEFIT and BEYOND. J Neurol 252 Suppl 3: iii44-iii50, 2005
38. Tintore M, Rovira A, Rio J, et al: Is optic neuritis more benign than other first attacks in multiple sclerosis?. Ann Neurol 57: 210-5, 2005
39. Wingerchuk DM: Neuromyelitis optica. Adv Neurol 98:319-33, 2006
40. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al: The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-14, 1999
41. Pittock SJ, Lennon VA, Krecke K, et al: Brain abnormalities in neuromyelitis optica. Arch Neurol 63: 390-6, 2006
42. Lennon VA, Wingerchuk DM, Kryzer TJ, et al: A serum auto-antibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-12, 2004
43. Lennon VA, Kryzer TJ, Pittock SJ, et al: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-7, 2005
44. Wingerchuk DM, Lennon VA, Pittock SJ, et al: Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-9, 2006
45. Weinshenker BG, Wingerchuk DM, Vukusic S, et al: Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59: 566-9, 2006
46. Keegan M, Pineda AA, McClelland RL, et al: Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58: 143-6, 2002
47. Mandler RN, Ahmed W, Dencoff JE: Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51: 1219-20, 1998
48. Cree BA, Lamb S, Morgan K, et al: An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64: 1270-2, 2005
49. Kennedy C, Carroll FD: Optic neuritis in children. Arch Ophthalmol 63: 747-55, 1960
50. Kriss A, Francis DA, Cuendet F, et al: Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatry 51: 1253-8, 1988
51. Parkin PJ, Hierons R, McDonald WI: Bilateral optic neuritis. A long-term follow-up. Brain 107 (Pt 3): 951-64, 1984
52. Haller P, Patzold U: [Optic neuritis in childhood (author's transl)]. Fortschr Neurol Psychiatr Grenzgeb 47: 209-16, 1979
53. Lucchinetti CF, Kiers L, O'Duffy A, et al: Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 49: 1413-8, 1997
54. Mizota A, Niimura M, Adachi-Usami E: Clinical characteristics of Japanese children with optic neuritis. Pediatr Neurol 31: 42-5, 2004
55. Tekavcic-Pompe M, Stirn-Kranjc B, Brecelj J: Optic neuritis in children - clinical and electrophysiological follow-up. Doc Ophthalmol 107: 261-70, 2003
56. Hwang JM, Lee YJ, Kim MK: Optic neuritis in Asian children. J Pediatr Ophthalmol Strabismus 39: 26-32, 2002
57. Morales DS, Siatkowski RM, Howard CWJ et al: Optic neuritis in children. J Pediatr Ophthalmol Strabismus 37: 254-9, 2000
58. Wilejto M, Shroff M, Buncic JR, et al: The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 67: 258-62, 2006